<SEC-DOCUMENT>0001062822-22-000010.txt : 20220317
<SEC-HEADER>0001062822-22-000010.hdr.sgml : 20220317
<ACCEPTANCE-DATETIME>20220317161724
ACCESSION NUMBER:		0001062822-22-000010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220317
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220317
DATE AS OF CHANGE:		20220317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXICON PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001062822
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				760474169
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30111
		FILM NUMBER:		22748746

	BUSINESS ADDRESS:	
		STREET 1:		2445 TECHNOLOGY FOREST BLVD.
		STREET 2:		SUITE 1100
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381
		BUSINESS PHONE:		2818633000

	MAIL ADDRESS:	
		STREET 1:		2445 TECHNOLOGY FOREST BLVD.
		STREET 2:		SUITE 1100
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON PHARMACEUTICALS, INC./DE
		DATE OF NAME CHANGE:	20070426

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON GENETICS INC/TX
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrx-20220317.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:42b69b05-0cea-4175-b0db-ec67eddf57a5,g:77fcc4c6-6e2d-456e-bc0f-9b74f98a69d1,d:5af93883694d4f3fa98fa0e1aa2b58b6--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lxrx-20220317</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl80L2ZyYWc6OGY4N2ZkYmZhMTZlNGY2Zjg0ZjBkODcxNjE0NjBlNDcvdGFibGU6YWU1MDJmNmZmMDUyNDY2YmFmN2U2ZGIwMDljNGM5ZDIvdGFibGVyYW5nZTphZTUwMmY2ZmYwNTI0NjZiYWY3ZTZkYjAwOWM0YzlkMl8wLTEtMS0xLTIzMzk3_42dbd478-9f0f-46fd-91ca-fd84c1b87e94">0001062822</ix:nonNumeric><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl80L2ZyYWc6OGY4N2ZkYmZhMTZlNGY2Zjg0ZjBkODcxNjE0NjBlNDcvdGFibGU6YWU1MDJmNmZmMDUyNDY2YmFmN2U2ZGIwMDljNGM5ZDIvdGFibGVyYW5nZTphZTUwMmY2ZmYwNTI0NjZiYWY3ZTZkYjAwOWM0YzlkMl8xLTEtMS0xLTIzMzk3_bcdc4807-3988-44d2-bf2d-53fd28db2698">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lxrx-20220317.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001062822</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-30</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5af93883694d4f3fa98fa0e1aa2b58b6_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk4_3ed0c167-ae5f-4ebb-a932-04bd2f73ce32">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18yNjU_62745d43-1f6e-4085-a9eb-59be39ebeedf">March 17, 2022</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk5_52c7abee-e01a-47a5-a054-ca79ba2eec6e">Lexicon Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:32.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6ODhkOTUwOWQyZTg5NDJkY2E3YWI0M2YyNDk3YjAyYjEvdGFibGVyYW5nZTo4OGQ5NTA5ZDJlODk0MmRjYTdhYjQzZjI0OTdiMDJiMV8wLTAtMS0xLTIzMzk3_6234e573-9569-44d8-a09c-e8536901ae18">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6ODhkOTUwOWQyZTg5NDJkY2E3YWI0M2YyNDk3YjAyYjEvdGFibGVyYW5nZTo4OGQ5NTA5ZDJlODk0MmRjYTdhYjQzZjI0OTdiMDJiMV8wLTEtMS0xLTIzMzk3_a63b32c8-5643-4bf6-bb80-608e1929bc5e">000-30111</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6ODhkOTUwOWQyZTg5NDJkY2E3YWI0M2YyNDk3YjAyYjEvdGFibGVyYW5nZTo4OGQ5NTA5ZDJlODk0MmRjYTdhYjQzZjI0OTdiMDJiMV8wLTItMS0xLTIzMzk3_5b92e06d-921e-4771-ace7-c414f4a14cdc">76-0474169</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjky_4bb31391-a036-4afa-96e8-0cc2d990d3ad">2445 Technology Forest Blvd., 11th Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNzAw_da18c4a7-70ef-4343-9cae-4716d44f3c65">The Woodlands</ix:nonNumeric>, <ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNzAx_26022964-45fd-4cfa-90d9-f82dc71d67c8">Texas</ix:nonNumeric> <ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y180MjA_b3fca50d-af8a-4004-94d1-28f64ed4786b">77381</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices and Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y180Nzk_fafd6a08-4413-4dbb-91e6-7f946bdd06b8">281</ix:nonNumeric>) <ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjkw_d246b118-404e-4d4c-9e85-b9896dcedeaa">863-3000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:34.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6OWJhM2MyOGY5NTMyNDY2ZTllNDJhYzU2MmMyZTk0YTIvdGFibGVyYW5nZTo5YmEzYzI4Zjk1MzI0NjZlOWU0MmFjNTYyYzJlOTRhMl8xLTAtMS0xLTIzMzk3_227068e0-c583-41df-b48c-9003ec9d032c">Common Stock, par value $0.001</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6OWJhM2MyOGY5NTMyNDY2ZTllNDJhYzU2MmMyZTk0YTIvdGFibGVyYW5nZTo5YmEzYzI4Zjk1MzI0NjZlOWU0MmFjNTYyYzJlOTRhMl8xLTEtMS0xLTIzMzk3_3da84091-0086-4f9b-9e32-ae412d0f5eff">LXRX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6OWJhM2MyOGY5NTMyNDY2ZTllNDJhYzU2MmMyZTk0YTIvdGFibGVyYW5nZTo5YmEzYzI4Zjk1MzI0NjZlOWU0MmFjNTYyYzJlOTRhMl8xLTItMS0xLTIzMzk3_411ab19f-624c-48b4-9707-f5c836bd5748">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjkx_24a4b5d2-62d8-4015-83e8-91defc65ed25">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjkz_66e1e3ce-0906-41f3-870e-67f973221348">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17&#160;CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk0_2f9a6997-2092-48e9-bf3b-82cb3c929d6c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR 240.14d-2(b))</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk1_a34123b4-38b7-4caa-81be-558e61382d35">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk3_89eda65c-a5aa-4ccc-be50-aabaa94ee134">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5af93883694d4f3fa98fa0e1aa2b58b6_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Item 1.01&#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">On March 17, 2022, Lexicon and one of its subsidiaries entered into a loan and security agreement with Oxford Finance LLC (&#8220;Oxford&#8221;) that provides up to $150 million in borrowing capacity (the &#8220;Oxford Term Loans&#8221;) available in four tranches, each maturing in March 2027.  Monthly interest-only payments are due during an initial 36-month period, which may be extended at Lexicon&#8217;s option to 48 months if Lexicon maintains compliance with a financial covenant relating to net sales of sotagliflozin following regulatory approval.  The interest-only period will be followed by an amortization period extending through the maturity date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The first $25 million tranche was funded at closing.  The second $25 million tranche is available for draw at Lexicon&#8217;s option prior to August 31, 2022, but within 30 days of acceptance of filing by the U.S. Food and Drug Administration of Lexicon&#8217;s resubmission of its application for U.S. regulatory approval of sotagliflozin for heart failure.  The third $50 million tranche is available for draw at Lexicon&#8217;s option prior to June 30, 2023, but within 60 days of U.S. regulatory approval of sotagliflozin for heart failure.  The fourth $50 million tranche is available for draw at Lexicon&#8217;s option, subject to Oxford&#8217;s consent, at any time prior to the expiration of the interest-only payment period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The loan and security agreement provides that, upon funding of the first three tranches, Lexicon will grant Oxford a warrant to purchase shares of its common stock having a value equal to 3.5%, 1.75% and 0.875%, respectively, of each such tranche, as determined by reference to a 10-day average closing price of the shares.  Each warrant will have an exercise price equal to such average closing price, be exercisable for a five-year period from the date of issuance and feature a net cashless exercise provision.  Concurrent with the funding of the first tranche, Lexicon granted Oxford a warrant to purchase 420,673 shares of Lexicon&#8217;s common stock at an exercise price of $2.08 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Oxford Term Loans bear interest at a floating rate equal to the 30-day U.S. Dollar LIBOR plus 7.90%, but not less than 8.01%, subject to additional interest if an event of default occurs and is continuing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If an event of default occurs and is continuing, Oxford may declare all amounts outstanding under the loan and security agreement to be immediately due and payable.  Lexicon may prepay the Oxford Term Loans in whole at its option at any time. Any prepayment of the Oxford Term Loans is subject to prepayment fees for up to three years after the funding of each tranche of the loans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A final payment equal to 6.0% of the amount funded under the Oxford Term Loans is due upon prepayment or maturity, which final payment will be adjusted to 7.0% of the amount funded upon extension of the interest-only payment period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Lexicon&#8217;s obligations under the Oxford Term Loans are secured by a first lien security interest in all of the assets of the Company and its subsidiaries.  The loan and security agreement contains certain customary representations and warranties, affirmative and negative covenants and events of default applicable to Lexicon and its subsidiaries.  In addition to the financial covenant, additional covenants include those restricting dispositions, fundamental changes to its business, mergers or acquisitions, indebtedness, encumbrances, distributions, investments, transactions with affiliates and subordinated debt.</span></div><div><span><br/></span></div><div id="i5af93883694d4f3fa98fa0e1aa2b58b6_120"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Item 2.03&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 2.03.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i5af93883694d4f3fa98fa0e1aa2b58b6_130"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Item 3.02&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.02.  The warrants discussed above and the underlying shares of common stock have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and they have been or will be issued in reliance upon the exemption from the registration requirements of the Securities Act provided by Section 4(2) thereof.</span></div><div><span><br/></span></div><div id="i5af93883694d4f3fa98fa0e1aa2b58b6_140"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Item 7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On March 17, 2022, Lexicon issued a press release announcing the execution of the loan and security agreement discussed above, a copy of which is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The information in Item 7.01 of this Current Report on Form 8-K, including the attached Exhibit 99.1, is being &#8220;furnished&#8221; pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i5af93883694d4f3fa98fa0e1aa2b58b6_10"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:13.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.061%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="pressrelease2022-03x17.htm">Press Release of Lexicon Pharmaceuticals, Inc. dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="pressrelease2022-03x17.htm">March 17</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="pressrelease2022-03x17.htm">, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EX-104</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5af93883694d4f3fa98fa0e1aa2b58b6_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:50.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lexicon Pharmaceuticals, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  March 17, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/ Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">President and General Counsel</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease2022-03x17.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5be2efdd983d493f8b17abaac432269b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">LEXICON ENTERS INTO LOAN FACILITY WITH OXFORD FINANCE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">FOR UP TO $150 MILLION TO SUPPORT PLANNED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">COMMERCIALIZATION OF SOTAGLIFLOZIN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">The Woodlands, Texas, March 17, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> - </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Lexicon Pharmaceuticals, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> (Nasdaq&#58; LXRX) today announced it entered into a loan facility with Oxford Finance LLC that provides up to $150 million in borrowing capacity designed primarily to support commercial preparations and the potential launch of sotagliflozin in heart failure.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;This loan facility provides us with access to a committed source of funding to support commercial preparations and the potential launch of sotagliflozin in heart failure along with substantial financial flexibility as we approach the planned resubmission of our New Drug Application for sotagliflozin in heart failure and expected topline results from two Phase 2 proof-of-concept studies of LX9211 in neuropathic pain,&#8221; said Jeffrey L. Wade, Lexicon&#8217;s president and chief financial officer.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The loan facility consists of up to four tranches, each maturing in March 2027.  An initial $25 million tranche was funded at closing.  The second $25 million tranche is available for draw at Lexicon&#8217;s option prior to August 31, 2022 contingent upon the acceptance of filing by the U.S. Food and Drug Administration of Lexicon&#8217;s planned resubmission of its application for U.S. regulatory approval of sotagliflozin for heart failure.  The third $50 million tranche is available for draw at Lexicon&#8217;s option prior to June 30, 2023 contingent upon U.S. regulatory approval of sotagliflozin for heart failure.  The final $50 million tranche is available for draw, at Lexicon&#8217;s option and subject to Oxford&#8217;s consent, at any time prior to the expiration of a three or four-year interest-only payment period.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The loan facility carries a floating interest rate equal to the 30-day U.S. Dollar LIBOR plus 7.90%, with a floor not less than 8.01%.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In connection with the initiation of the facility and first tranche funding, Lexicon granted Oxford a warrant to purchase 420,673 shares of Lexicon&#8217;s common stock at an exercise price of $2.08 per share, exercisable through March 17, 2027.  Upon funding of the second and third tranches, Lexicon will grant Oxford warrants to purchase additional shares of its common stock having a value equal to 1.75% and 0.875%, respectively, of each such tranches.  Each warrant will have an exercise price equal to an average closing price of the shares prior to the warrant&#8217;s grant and will be exercisable for a five-year period.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Lexicon&#8217;s obligations under the loan facility are secured by a first lien security interest in all of the assets of Lexicon and its subsidiaries and are subject to customary affirmative and negative covenants, including a financial covenant relating to net sales of sotagliflozin following regulatory approval.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About Oxford Finance LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. Since 2002, Oxford has originated approximately $8.8 billion in loans. Oxford is headquartered in Alexandria, Virginia, with additional offices in California (San Diego, Palo Alto, and Los Angeles), and the greater Boston and New York City metropolitan areas. For more information, visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">www.oxfordfinance.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About Sotagliflozin </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Discovered using Lexicon&#8217;s unique approach to gene science, sotagliflozin is an investigational oral dual inhibitor of two proteins responsible for glucose regulation known as sodium-glucose co-transporter types 1 and 2 (SGLT1 and SGLT2). SGLT1 is responsible for glucose absorption in the gastrointestinal tract, and SGLT2 is responsible for glucose reabsorption by the kidney. Sotagliflozin is approved in the European Union (EU) for use as an adjunct to insulin therapy to improve blood sugar (glycemic) control in adults with type 1 diabetes with a </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">body mass index &#8805; 27 kg&#47;m</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:112%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, who could not achieve adequate glycemic control despite optimal insulin therapy, but has not yet been commercially launched. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About Lexicon Pharmaceuticals </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients&#8217; lives. Through its Genome5000&#8482; program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon advanced one of these medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, diabetes and metabolism and other indications.  For additional information, please visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">www.lexpharma.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Safe Harbor Statement</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">This press release contains &#8220;forward-looking statements,&#8221; including statements relating to Lexicon&#8217;s financial position and long-term outlook on its business, including the clinical development of, regulatory filings for, and potential therapeutic and commercial potential of sotagliflozin, LX9211 and its other potential drug candidates. In addition, this press release also contains forward looking statements relating to Lexicon&#8217;s growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management&#8217;s current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including Lexicon&#8217;s ability to meet its capital requirements, successfully conduct preclinical and clinical development and obtain necessary regulatory approvals of sotagliflozin, LX9211 and its other potential drug candidates on its anticipated timelines, successfully commercialize any products for which it obtains regulatory approval, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates. Any of these risks, uncertainties and other factors may cause Lexicon&#8217;s actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under &#8220;Risk Factors&#8221; in Lexicon&#8217;s annual report on Form 10-K for the year ended December 31, 2021, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5be2efdd983d493f8b17abaac432269b_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">For Inquiries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%">&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%">Chas Schultz</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%">Executive Director, Corporate Communications and Investor Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%">Lexicon Pharmaceuticals</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%">(281) 863-3421</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%">cschultz&#64;lexpharma.com</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lxrx-20220317.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:42b69b05-0cea-4175-b0db-ec67eddf57a5,g:77fcc4c6-6e2d-456e-bc0f-9b74f98a69d1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lxrx="http://www.lexpharma.com/20220317" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lexpharma.com/20220317">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20220317_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20220317_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.lexpharma.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lxrx-20220317_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:42b69b05-0cea-4175-b0db-ec67eddf57a5,g:77fcc4c6-6e2d-456e-bc0f-9b74f98a69d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_f3c789b1-2dd2-4cf8-a87a-361ba0ac6281_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_83610161-4d58-4c71-bded-fe7057a429f8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_6524f7c7-9dd0-4c3a-9a56-5cf883e8bc3b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_92a9b81c-ad05-4431-b61d-e4bac54fefa0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_a23b2c0c-b5c5-4883-b420-c7e1d8e34fb5_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_32fdb979-e55b-4d10-a76f-26a02a7c67cf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_27fc331f-5131-4053-bc3f-9f8829bf0748_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_850b9cfd-7ba0-422f-9238-796841e278dd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a56991f4-2609-4d5f-ad18-b9251bea59af_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_107804dd-ceb2-4e5c-80f3-5de052da9b83_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_bc1acfbd-7689-40f4-9334-0b0e93ab7b1e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a49569e9-5beb-4a62-95a8-78859946071e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_26ba0d32-0f8d-4394-b579-5121f308e3ab_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ceb0520d-0ffe-4524-88a5-26638d81f5b9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8c8c7730-a441-49c0-9528-4ca159858288_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_47579dff-5c6c-4381-8fc5-1b732e3311bc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c656bca4-65c0-4fbf-83a5-f38a555acd06_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1914eb87-d31c-4a5f-ad24-3ddc2926fcce_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0497de31-1be2-439d-a6d8-e6664e0c5b23_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_769eb035-ddb2-4e5f-a0ea-3ceeb3ea7448_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f509c040-94c5-4635-ac8c-c5f11edb225f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7012ebac-564d-42fa-bbd2-944249a4200e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>lxrx-20220317_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:42b69b05-0cea-4175-b0db-ec67eddf57a5,g:77fcc4c6-6e2d-456e-bc0f-9b74f98a69d1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20220317.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.lexpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fe8bd9c0-3f6f-4098-b833-448d23e3f16d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_DocumentType_fe8bd9c0-3f6f-4098-b833-448d23e3f16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d6e5b85e-94c5-4696-a3ec-f72f169104e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_DocumentPeriodEndDate_d6e5b85e-94c5-4696-a3ec-f72f169104e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2bd73703-99db-47c5-bc5e-867d573b4620" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityRegistrantName_2bd73703-99db-47c5-bc5e-867d573b4620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b0982cb0-716d-4a5a-ad59-652725224b4d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b0982cb0-716d-4a5a-ad59-652725224b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_78bb39b4-5eba-467d-b5eb-410b5d6ebef3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityFileNumber_78bb39b4-5eba-467d-b5eb-410b5d6ebef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_74cb33ad-c3f6-493d-a431-0489b39eba2f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityTaxIdentificationNumber_74cb33ad-c3f6-493d-a431-0489b39eba2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ddf0fed8-43ee-450d-89b8-242f0c0de424" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityAddressAddressLine1_ddf0fed8-43ee-450d-89b8-242f0c0de424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_17e05434-28e3-4333-b0d4-2cfe6533f966" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityAddressCityOrTown_17e05434-28e3-4333-b0d4-2cfe6533f966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_64657c71-9eab-4cf1-95f0-57b57b85766e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityAddressStateOrProvince_64657c71-9eab-4cf1-95f0-57b57b85766e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_62ba0ab7-4d47-4b91-8999-78e9df363b27" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityAddressPostalZipCode_62ba0ab7-4d47-4b91-8999-78e9df363b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f11f98a9-2be4-4a68-bd29-4c8d102efc87" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_CityAreaCode_f11f98a9-2be4-4a68-bd29-4c8d102efc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6684b525-a62e-4079-9740-66ee0c218e6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_LocalPhoneNumber_6684b525-a62e-4079-9740-66ee0c218e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1902ab5b-9ba8-4544-8e8e-321e1f285785" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_Security12bTitle_1902ab5b-9ba8-4544-8e8e-321e1f285785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b80759a4-7648-4b9b-b689-347b100028cd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_TradingSymbol_b80759a4-7648-4b9b-b689-347b100028cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_14459355-0223-4138-a321-e5900e91e56f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_SecurityExchangeName_14459355-0223-4138-a321-e5900e91e56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_87ae70d0-c8bd-404f-86fe-aa80056dd220" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_WrittenCommunications_87ae70d0-c8bd-404f-86fe-aa80056dd220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_2069f521-75ec-41bf-93fb-3c477f2a3535" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_SolicitingMaterial_2069f521-75ec-41bf-93fb-3c477f2a3535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_fcca2ab7-b7fd-458c-960a-ccd529a3403e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_PreCommencementTenderOffer_fcca2ab7-b7fd-458c-960a-ccd529a3403e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e4e69db6-76ea-4a4f-b9a1-1badda26df40" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e4e69db6-76ea-4a4f-b9a1-1badda26df40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5ef0b31a-c3aa-40f8-b9bb-f69601d94fbc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityEmergingGrowthCompany_5ef0b31a-c3aa-40f8-b9bb-f69601d94fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_35951726-21c5-4776-9156-ef1b2e296814" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_EntityCentralIndexKey_35951726-21c5-4776-9156-ef1b2e296814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6363b18d-4559-4c90-910f-c04736d18caf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_608e3eff-0700-4f0c-b839-c069cddd84d3" xlink:to="loc_dei_AmendmentFlag_6363b18d-4559-4c90-910f-c04736d18caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140501562447656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 17,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Lexicon Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0474169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2445 Technology Forest Blvd., 11th Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">The Woodlands<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">863-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LXRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001062822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>lxrx-20220317_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrx-20220317.xsd" xlink:type="simple"/>
    <context id="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001062822</identifier>
        </entity>
        <period>
            <startDate>2021-07-30</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl80L2ZyYWc6OGY4N2ZkYmZhMTZlNGY2Zjg0ZjBkODcxNjE0NjBlNDcvdGFibGU6YWU1MDJmNmZmMDUyNDY2YmFmN2U2ZGIwMDljNGM5ZDIvdGFibGVyYW5nZTphZTUwMmY2ZmYwNTI0NjZiYWY3ZTZkYjAwOWM0YzlkMl8wLTEtMS0xLTIzMzk3_42dbd478-9f0f-46fd-91ca-fd84c1b87e94">0001062822</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl80L2ZyYWc6OGY4N2ZkYmZhMTZlNGY2Zjg0ZjBkODcxNjE0NjBlNDcvdGFibGU6YWU1MDJmNmZmMDUyNDY2YmFmN2U2ZGIwMDljNGM5ZDIvdGFibGVyYW5nZTphZTUwMmY2ZmYwNTI0NjZiYWY3ZTZkYjAwOWM0YzlkMl8xLTEtMS0xLTIzMzk3_bcdc4807-3988-44d2-bf2d-53fd28db2698">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk4_3ed0c167-ae5f-4ebb-a932-04bd2f73ce32">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18yNjU_62745d43-1f6e-4085-a9eb-59be39ebeedf">2022-03-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk5_52c7abee-e01a-47a5-a054-ca79ba2eec6e">Lexicon Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6ODhkOTUwOWQyZTg5NDJkY2E3YWI0M2YyNDk3YjAyYjEvdGFibGVyYW5nZTo4OGQ5NTA5ZDJlODk0MmRjYTdhYjQzZjI0OTdiMDJiMV8wLTAtMS0xLTIzMzk3_6234e573-9569-44d8-a09c-e8536901ae18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6ODhkOTUwOWQyZTg5NDJkY2E3YWI0M2YyNDk3YjAyYjEvdGFibGVyYW5nZTo4OGQ5NTA5ZDJlODk0MmRjYTdhYjQzZjI0OTdiMDJiMV8wLTEtMS0xLTIzMzk3_a63b32c8-5643-4bf6-bb80-608e1929bc5e">000-30111</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6ODhkOTUwOWQyZTg5NDJkY2E3YWI0M2YyNDk3YjAyYjEvdGFibGVyYW5nZTo4OGQ5NTA5ZDJlODk0MmRjYTdhYjQzZjI0OTdiMDJiMV8wLTItMS0xLTIzMzk3_5b92e06d-921e-4771-ace7-c414f4a14cdc">76-0474169</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjky_4bb31391-a036-4afa-96e8-0cc2d990d3ad">2445 Technology Forest Blvd., 11th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNzAw_da18c4a7-70ef-4343-9cae-4716d44f3c65">The Woodlands</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNzAx_26022964-45fd-4cfa-90d9-f82dc71d67c8">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y180MjA_b3fca50d-af8a-4004-94d1-28f64ed4786b">77381</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y180Nzk_fafd6a08-4413-4dbb-91e6-7f946bdd06b8">281</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjkw_d246b118-404e-4d4c-9e85-b9896dcedeaa">863-3000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6OWJhM2MyOGY5NTMyNDY2ZTllNDJhYzU2MmMyZTk0YTIvdGFibGVyYW5nZTo5YmEzYzI4Zjk1MzI0NjZlOWU0MmFjNTYyYzJlOTRhMl8xLTAtMS0xLTIzMzk3_227068e0-c583-41df-b48c-9003ec9d032c">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6OWJhM2MyOGY5NTMyNDY2ZTllNDJhYzU2MmMyZTk0YTIvdGFibGVyYW5nZTo5YmEzYzI4Zjk1MzI0NjZlOWU0MmFjNTYyYzJlOTRhMl8xLTEtMS0xLTIzMzk3_3da84091-0086-4f9b-9e32-ae412d0f5eff">LXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGFibGU6OWJhM2MyOGY5NTMyNDY2ZTllNDJhYzU2MmMyZTk0YTIvdGFibGVyYW5nZTo5YmEzYzI4Zjk1MzI0NjZlOWU0MmFjNTYyYzJlOTRhMl8xLTItMS0xLTIzMzk3_411ab19f-624c-48b4-9707-f5c836bd5748">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjkx_24a4b5d2-62d8-4015-83e8-91defc65ed25">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjkz_66e1e3ce-0906-41f3-870e-67f973221348">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk0_2f9a6997-2092-48e9-bf3b-82cb3c929d6c">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk1_a34123b4-38b7-4caa-81be-558e61382d35">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhZjkzODgzNjk0ZDRmM2ZhOThmYTBlMWFhMmI1OGI2L3NlYzo1YWY5Mzg4MzY5NGQ0ZjNmYTk4ZmEwZTFhYTJiNThiNl8xL2ZyYWc6NWM2MDVmZjlhOGJkNGIzZDg4OGU5MTVmNWRkZWE0N2MvdGV4dHJlZ2lvbjo1YzYwNWZmOWE4YmQ0YjNkODg4ZTkxNWY1ZGRlYTQ3Y18xNjk3_89eda65c-a5aa-4ccc-be50-aabaa94ee134">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ *X)Q5)>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ *X)Q5"0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  K@G%4/VV3-NX    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  K
M@G%4F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( "N"<51,FP8G0P0  $D0   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  K
M@G%4GZ ;\+$"  #B#   #0              @ &&#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( "N"<527BKL<P    !,"   +              "  6(/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( "N"<52JQ"(6,P$  "("   /
M          "  4L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  K@G%4
M)!Z;HJT   #X 0  &@              @ &K$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    "  K@G%499!YDAD!  #/ P  $P
M        @ &0$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  #:$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lxrx-20220317.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lexpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lxrx-20220317.htm">lxrx-20220317.htm</File>
    <File>lxrx-20220317.xsd</File>
    <File>lxrx-20220317_lab.xml</File>
    <File>lxrx-20220317_pre.xml</File>
    <File>pressrelease2022-03x17.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lxrx-20220317.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "lxrx-20220317.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lxrx-20220317_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrx-20220317_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lxrx-20220317.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lxrx",
   "nsuri": "http://www.lexpharma.com/20220317",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20220317.htm",
      "contextRef": "ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.lexpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20220317.htm",
      "contextRef": "ibdb445add57a4166aa5e64a7e38ccfa7_D20210730-20210730",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001062822-22-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062822-22-000010-xbrl.zip
M4$L#!!0    ( "N"<51:-%/$EQH  ,Z8   1    ;'AR>"TR,#(R,#,Q-RYH
M=&WM76E3V\C6_GY_1;^>F7N9*F2T6W(2;A$,7&>PG0$3QOY"M=0M6Z#%(\E@
M\^O?<UJ2%\!@DK!EDJHDMM7K69ZS]*+W_YV$ ;GD2>K'T8>*4I4KY+_;[_]/
MDO[Z>'1(&K$[#GF4D=V$TXPS<N5G0W+*>'I!O"0.R6F<7/B75))$G=UX-$W\
MP3 CJJRJ-QXF=5UU3-N1#4EV.95TI69(CLP<B;MFC3/F&35J; [JM9KGNKIK
M2B97F:0;)I<<5_8DVZGIGFU1TV;*)JL;U+,UR]),6V>ZIWG4MCPJ<X52U3$L
MQ\1NAQG,#F88I1\JPRP;U;>VKJZNJE=:-4X&6XIMVUL3+%/)"]4G3A+X2T7Q
M%U%8E65MRX_2C$8N+\LS/B\M2J;<K0[BRRUX #5469(525/*XOXDDZ#$4@=E
M#3\*_(@CU;>RA$:I%R<AS8 KT(X")+,6VIFD_EWS@2$J6W^U#H_=(0^I='.P
M_F35S!1MH?M9)_##Q6JRX=.%>=W=]'V30N*HDJ*6C=SJ;IGT^-BA:3Z;>D"C
MP8<*CZ23XPJPF5.V_3[D&2587^)_C_W+#Y7=.,I >*7N= 35W/S;ATK&)]F6
MX/K6]K_^]:_WF9\%?#N8)!,)Q5;6E-K[K?S']UMYTT[,IMOOF7])TFP:\ \5
MYJ>C@$[K41QQ&( _J6-!GN0??<9X)#["\S9H4.*[>?^3[(A['RJ^PQQ=-RAC
M(/.Z8IJ4&MS4:8UKENMZM';6@*$H<DV3I?)#A40TQ*ZY7]^+8'S379A.0H-F
MQ/CD#SZM$)]!TTS[,G4:\>6A>G39TUIC=KYWV3^PSSOG7X;]\XOK3F-PW3Z_
MD/N-H["E]H>=[C#L=3\&K=/]82ML*IV#IGJHM8/>=:ST3GM&ZWJ@MZY[1OO@
M3[E_WH:R%WH_W+OJ=_>'O>XGO]T=^NW D@_5_K1WZIJ=@Y[>5OL7O; _;'7[
M0?N@I_;/!U#WXT6GX4[:YWMR^_QCT&ZXE^Q@WW<.3LS>Z8G2:GP*VV$_;#5.
MINU&3^V%^V%;/5'[!\VK5B,X;Q^TC'ZC6=3Y GT94;\[&O:[)U>M$/H(>U?M
M;A/:[OLP;JW?A3&<[UQU3EMR[SJX: 76U6%W+VL=RY/#;O.Z=7VAG>DJ<YA>
MLR3; X3138])MN)2R6.6[BJ.5>.V7MF60;%D4[54]?W6$E.?DL<[ +P,P7<_
MH(,*R54'FIUD=<^?<"9Y-$!U^,GT^YD^N<5TQV6N;LDU2;,M2])UIDJ.!Z;&
MT#RF6LQ13=NJ;._O'![OW>+WUK)^)]SC"0>03>^ )82L>BK &"2"",BL9P!&
M'RJI'XX"Q#+QVS!!@5E"H.HD9=#$UG(;>?_S3HLQI/$X$=^$_:H74IA+QM=(
M8=D0%S!3?O,9?O=\GA Q('ZG'=MM_K&L,#<K;Y<_+;<^ OK&K/P&EBO)&N!R
M;..@).257-:;/YL-DZTH6CXIOY>=;"T1JJ3JC(Q;"WB^!:B?0[\@YT->QYE2
M6:Q3F(O0CZ0A1\\(G*!JS1AE[ZY\E@WKBBS_5A%%M]^G(PI"Y21;T$#^.6_G
M5FOH0T@P[H2Z63T=AR%-IM!(1IV EV6<.('A2VX<!'24\GKYX5UIN7+3+(E*
M[Z"% 0S1B;,L#NLX/' ),]^E@40#?Q#5D4S%X_G(JW(^^@S(E+&RY^)Q53S:
MRMCM9[95M>75C^6J,GNV)=I.R@(%#6& %5$/9H64^E#1*C<F7DQ%'64DC0.?
MD5]D\>?="%3!CP9UF2BBE7DW6X(6"_1>S9(%9@C*Y$1R0:)Y4LFKE<]AB'%2
M+WOW0.( N$,_F-;_T_5#P(TVOR)'<4BC_VRFX"(!<Q/?RPNF_C6O*S"'_.M5
M/OL:M"-X5U!#49&6)^UF=Z]!CKL[W;WC5S_:X[W=DZ-FM[EW3';:#;+WU^[_
M=MH'>V2WTVHUCX^;G?8+3D%9:PJG-!V"(&5QM$D:U=TJQ#R&;K\BRNMW#OOL
MUI]UAGP^3@&]IY77H1*JO!:']CM'+?*$'EH9'>?QQ4OZ89/2#VN?MM16XTO8
M/P^&G8-/%^V#YG6_,= [!R=&J_LE;)\>7?1/P1=36^!3?='9_SX%?36X=,ZA
MOVOPI4[[8>=T3^^%?\J]\S;X;@.]W[V8M$][2O_@*.AU_]1ZB@7^W(5^IG$F
MNXI9DR@WP'GFCB-16U,E67>8ZM4TEVMJ9=N2_KCM1?U4DJ>?JKF6D@ .'^VU
MN^1H[W/GJ/N*.'/W<#^/DW1,HXQD,3GF+N82B**1."&*L<%^)[%'LB''1^/$
MSWSH>&_B#L$MYV3'S?"Q8FOZK6F^$I:M1P-T:7$F1WP4)QG9*+]S"DXM3S/"
M+S%GEXC'G/U>?PX0_"Q<Z[W<X5X.5QG\(H70YQ"K28Q.I2F,5>+1/PLUI^WS
MDS-3K>D&TS5)\4PNZ;)E &AR1S)LAVOP@7/F5;9;-'&'1*EMBDSJU^#GZP*C
M-2WVDZ?,COC 3S$5F;7AR3]+_-!H&V>&ZM8H2)G$985*>HV"_('C*KFT9CM4
MY=PU>67[D$]\H#[Y/*2@QRX?BV PW23-R*V^(G.^GEAM[$T@5!;"@#B9S(2
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M!*^6@/,%%ZGW5A">/%+W7CUVYYOQRND>B-GNYI/]"=LW8%L[LVS.J&FX$C4
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MN"8P?EQJ*ND"-*D!=+?P9J1 \)WC"2@ICN#;B$YQCBGNPB1LC']%;8K#!&D
MP=#,_%:EP@)M%GN'0CHESH*I@DD7=)_M^HQ'PJ# _'6+B#92M(,E>T(*8X&_
M:6[0?$'8W*(M&# WON01%1=-(0S!V*"]B />T8"+1;$TSN@@\+T@OA9$*9?
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MO.-C<,8T4'\E'P(&O.U<B,/(6G@]"/T6J3W@/7OHGP@AC;/22CI977-1R)W
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M'?=[OQT/B(G+<W%].3C^J=\[[U_^UKOX;!8V6-?F6;^7SNMD^M\W(^9\,%9
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M 5*Q<*X@=9D&S5YUG&D:$K,-?O:;.?G-Q8KCH2G]AHSU6^%JLSZO\$-QC"#
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M3:PUO3Y3!4T:PL&/-RGWD@HO./GJX)?L#II7TG.^/-+8;!*";R2[>3EU$6A
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M   1              "  0    !L>')X+3(P,C(P,S$W+FAT;5!+ 0(4 Q0
M   ( "N"<5158:2#< (  'T'   1              "  <8:  !L>')X+3(P
M,C(P,S$W+GAS9%!+ 0(4 Q0    ( "N"<52!D[LK00H  *)=   5
M      "  64=  !L>')X+3(P,C(P,S$W7VQA8BYX;6Q02P$"% ,4    "  K
M@G%4<PDB!:H&  !H,0  %0              @ '9)P  ;'AR>"TR,#(R,#,Q
M-U]P<F4N>&UL4$L! A0#%     @ *X)Q5+( 3138#@  TC<  !H
M     ( !MBX  '!R97-S<F5L96%S93(P,C(M,#-X,3<N:'1M4$L%!@     %
-  4 3 $  ,8]      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
